390 related articles for article (PubMed ID: 16829051)
1. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
[TBL] [Abstract][Full Text] [Related]
2. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Loba J; Markuszewski L
Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
[TBL] [Abstract][Full Text] [Related]
3. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
4. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
Honderlick P; Cahen P; Gravisse J; Vignon D
Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
[TBL] [Abstract][Full Text] [Related]
5. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
Karaca Y; Coplu N; Gozalan A; Oncul O; Citil BE; Esen B
Int J Antimicrob Agents; 2005 Jul; 26(1):75-7. PubMed ID: 15955672
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
7. Fosfomycin tromethamine: single-dose treatment of acute cystitis.
Stein GE
Int J Fertil Womens Med; 1999; 44(2):104-9. PubMed ID: 10338268
[TBL] [Abstract][Full Text] [Related]
8. Management of complicated urinary tract infections in the era of antimicrobial resistance.
Bader MS; Hawboldt J; Brooks A
Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
[TBL] [Abstract][Full Text] [Related]
9. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
Patel SS; Balfour JA; Bryson HM
Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
[TBL] [Abstract][Full Text] [Related]
10. The expanding role of fluoroquinolones.
Schaeffer AJ
Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
[TBL] [Abstract][Full Text] [Related]
11. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
12. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract infection: traditional pharmacologic therapies.
Nicolle LE
Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment and resistance of unselected uropathogens in the elderly.
Nys S; van Merode T; Bartelds AI; Stobberingh EE
Int J Antimicrob Agents; 2006 Mar; 27(3):236-41. PubMed ID: 16473503
[TBL] [Abstract][Full Text] [Related]
15. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen P; Honderlick P
Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
[TBL] [Abstract][Full Text] [Related]
17. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
18. [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006].
Florea C
Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957
[TBL] [Abstract][Full Text] [Related]
19. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
Wagenlehner FM; Naber KG
Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobials in urogenital infections.
Wagenlehner FM; Wullt B; Perletti G
Int J Antimicrob Agents; 2011 Dec; 38 Suppl():3-10. PubMed ID: 22019184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]